PAG
CVS icon

Paladin Advisory Group’s CVS Health CVS Stock Holding History

Paladin Advisory Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-574
Closed -$25.8K – 235
2024
Q4 		$25.8K Hold
574
– – 0.02% 174
2024
Q3 		$36.1K Hold
574
– – 0.03% 166
2024
Q2 		$33.4K Hold
574
– – 0.03% 160
2024
Q1 		$45.7K Sell
574
-41
-7% -$3.13K 0.04% 151
2023
Q4 		$48.6K Hold
615
– – 0.04% 145
2023
Q3 		$42.9K Sell
615
-309
-33% -$21.9K 0.04% 156
2023
Q2 		$63.9K Hold
924
– – 0.05% 143
2023
Q1 		$68.7K Buy
+924
New +$77.5K 0.06% 141
2022
Q2 		– Sell
-1,094
Closed -$107K – 332
2022
Q1 		$110K Buy
+1,094
New +$115K 0.09% 126

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Paladin Advisory Group's CVS Position: Q1 2025 in Review

Paladin Advisory Group sold out of CVS Health (CVS) in Q1 2025, closing a stake of 574 shares — an estimated $25.8K sold.

Paladin Advisory Group first reported a position in CVS in Q1 2022 and held it in 9 quarters. The position peaked at $110K in Q1 2022. 1,756 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Paladin Advisory Group reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Paladin Advisory Group sold 574 CVS Health shares in Q1 2025, an estimated $25.8K.
  • Paladin Advisory Group first reported a position in CVS Health in Q1 2022 and held it in 9 quarters.
  • Paladin Advisory Group's CVS Health position peaked at $110K in Q1 2022.
  • 1,756 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Paladin Advisory Group's 13F filing for Q1 2025, filed 15 Apr 2025.